A distinguished Professor Ben M. Dunn received his Ph.D. in Chemistry from the University of California at Santa Barbara in 1971 and did postdoctoral work at the National Institutes of Health from 1971-1974. He joined the Department of Biochemistry and Molecular Biology in 1974 and moved through the ranks to his current title. He served as President of the American Peptide Society from 2011-2013 and was President of the International Proteolysis Society. He is the Editor-in-Chief of two Bentham journals, Protein and Peptide Letters, for research reports and mini-reviews, and Current Protein and Peptide Science, which publishes exclusively review papers.
Dr. Coskuner-Weber obtained a Ph.D. degree from the Universitaet zu Köln (Germany), then worked at Johns Hopkins University (Maryland, USA). Dr. Weber also worked at the National Institute of Standards and Technology (Maryland, USA) along with an academic appointment at Stanford University (California, USA). Currently, Dr. Weber is an Associate Professor of Molecular Biotechnology at the Turkish-German University (Istanbul, Turkey). Dr. Weber has published more than a number of scientific publications and has served on the editorial boards of a number of journals and was also appointed as Associate Editor of this journal (Protein & Peptide Letters), published by Bentham Science Publishers.
Dr. Rizwan Hasan Khan has received his Ph.D in Biotechnology from Aligarh Muslim University, India during the period of 1992-1996. Currently he is working in the area of protein structure, function, protein misfolding / aggregation and amyloid induction and inhibition at Aligarh Muslim University. He has published paper in journals like Scientific reports, Biomacromolecules, Langmuir, PLoS ONE, Biochemistry, BBA, BBRC etc. He has worked with Prof. I.J. Goldstein at the University of Michigan USA as BOYSCAST Fellow and with Prof. Steve Perkins at the University of London as Commonwealth Fellow. He has guided 16 PhD thesis and completed 12 research projects. He had published around 250 papers in the journals of international repute with H index of 35 and total citations around 4650.
Prof. M. Akhter Hossain completed his Ph.D. in 2001 at Tokyo Institute of Technology (Japan) and undertook postdoctoral studies at Joseph Fourier University (France) and the Howard Florey Institute (Australia). He has been the Head of the Insulin Peptides Laboratory since 2012 at the now- Florey Institute of Neuroscience and Mental Health, University of Melbourne. He has published > 115 papers from 2000 to mid-2018 in the key international journals including the Journal of American Chemical Society, Angewandte Chemie, and Chemical Science. Five of his discoveries have been patented. His research group is interested in designing peptidomimetics and developing novel chemical methods for preparing therapeutic insulin and insulin-like peptides.
Dr. Emanuele Papini graduated in Biology in 1983, and was post-graduate fellow at the University of Verona (Italy) between 1983 and 1985 working with Prof. P. Bellavite and Prof. F. Rossi on NADPH-oxidase activation mechanism. He obtained Ph.D. in 1990 from the University of Padova in the laboratory of Prof. C. Montecucco, working on the intoxication mechanism of diphtheria toxin in collaboration with Dr. R. Rappuoli. In 1991, he became the researcher at the Department of Biomedical Sciences, University of Padova. 1993-1994. Fellow scientist, Laboratory for Molecular Cell Biology, UCL, UK, working on intracellular trafficking of bacterial toxins with Prof. D. Cutler and Prof. C. Hopkins. In 1998, he became Professor of General Pathology, University of Bari. In 2001, he became PI, Department of Biomedical Science, University of Padova. His teaching activities include General Pathology, Immunology, Immunological Biotechnology, and Nanobiotechnology. His main research projects are in the field of bacterial toxins and adhesions action mechanisms, nanoparticles and peptides in medicine and pathology. He is the author in about 92 scientific publications and inventor of two patents.
Dr. Predrag Cudic earned his Ph.D, degree in Chemistry from the University of Zagreb, College of Science, Croatia, in 1996. He then joined the group of Prof. Jean-Marie Lehn, winner of the 1987 Nobel Prize in Chemistry, at the Collège de France in Paris, France, as a Postdoctoral Research Associate. At the University of Pennsylvania, Dr. Cudic's research was focused on the total solid-phase synthesis of a novel peptide antibiotic ramoplanin, its mechanism of action and structure-activity relationship. His research interests at that time were focused on the design and synthesis of biomimetic carbohydrate receptors, and solid-phase synthesis and biological evaluation of nonribosomal peptide natural products.
Dr. Ramos is a Full Professor in the Federal University of Ceará Brazil. He holds a Doctorate in Protein Biochemistry from the Federal University of Ceará, Brazil with a one and a half year at Université Paul Sabatier, Toulouse, France and a post-doctoral stage at Université des Sciences et Technologies de Lille, France. For nearly 20 years he has studied plant proteins in terms of chemistry, structure, functions and biotechnological applications. Currently he investigates the role of latex proteins in plant defense against enemies and the potential use of latex proteins as biotechnological tools in agriculture and medicine.
Dr. Uversky obtained Ph.D. from Moscow Institute of Physics and Technology (1991) and D.Sc. from Institute of Experimental and Theoretical Biophysics (1998). Dr. Uversky is an Associate Professor at the Department of Molecular Medicine at the University of South Florida. He has authored over 600 scientific publications and edited several books and book series on intrinsically disordered proteins, protein structure, function, folding and misfolding. Dr. Uversky is an Editor-in-Chief of the Intrinsically Disordered Proteins journal and an editor of several other scientific journals, including Current Protein & Peptide Science, Protein & Peptide Letters, PeerJ, and Biochemistry & Biophysics Reports.
Dr. Gomez-Casati received his BS in biochemistry from the National University of Rosario, Argentine, and his Ph.D. in biochemistry from the University of Buenos Aires. He conducted postdoctoral research at the Chascomus Institute of Technology, Argentine, and Bordeaux 2 University, France. He was a visiting scientist at California State University, Fullerton, USA, Laboratoire Microbiologie Cellulaire et Moleculaire et Pathogenicite, Centre National de la Recherche Scientifique (CNRS), Université Bordeaux-2, and Pontificia Universidad Católica de Chile. He was a professor of plant biotechnology at the National University of San Martín (UNSAM). At present, he is a researcher at the National Research Council, Argentine (CONICET), Director of the Plant Molecular Biology and Biotechnology Laboratory at the Institute for Photosynthetic and Biochemical Studies (CEFOBI-CONICET), and Professor at the National University of Rosario.
Alexsandro Sobreira Galdino obtained master's in Biochemistry from Universidade Federal do Ceara during 2001-2002. He became a substitute professor of Biology at Universidade Federal do Ceará (2003). He completed Ph.D in Molecular Biology from Universidade de Brasília (2004-2008) and Post-doctoral in biotechnology immunology from the same university. Dr. Galdino has been involved in the purification of novel recombinant antigens for immunological diagnosis kit. AS Galdino is an associate professor of Biotechnology at Universidade Federal de São João Del-Rei since 2010.
Tim Kamerzell received his PhD in Pharmaceutical Chemistry from The University of Kansas in Lawrence, KS where he studied the relationships between protein dynamics and thermodynamic stability. In 2007, Kamerzell joined Genentech, Inc. a South San Francisco based biotechnology company in the Department of Late-Stage Pharmaceutical Development where he helped design protein-based therapeutics. While at Genentech, he focused on understanding the chemical and physical mechanisms of protein degradation including methods to prevent them. Kamerzell subsequently obtained a medical degree from The University of Kansas and completed Internal Medicine Residency training at Washington University in St Louis.
Dr. Sara Missaglia obtained her PhD in Biology from Bicocca University, Milan. Then she moved to the Catholic University of the Sacred Heart, where she is currently working in the Laboratory of Cellular Biochemistry and Molecular Biology (Research Centre of Biochemistry and Sport Nutrition-CRIBENS). From 2020, she is working as Assistant Professor of Biochemistry at the same university. The most important research interest has been the study of lipid metabolism, in particular, biochemical and molecular aspects of rare diseases due to an inborn error of neutral-lipid hydrolysis.
Maria Luisa Mangoni graduated in Biology with honours at Sapienza University of Rome. In 1998, she worked at Karolinska Institutet, Stockholm, in the lab of Prof. Emeritus Hans G. Boman where she studied the role of antimicrobial peptides (AMPs) in innate immunity. In 2002, she received her PhD in Biochemistry from Sapienza University. In 2002, she was appointed as Assistant Professor and in 2012 as Associate Professor, in the same University. In 2014, she became Full Professor of Biochemistry. Her current research interests include the structural functional characterization of amphibian skin AMPs and their derivatives for the development of new anti-infective agents. She was an invited speaker at several international conferences.
Yiqiang Wang received a Bachelor of Medicine (MD equivalent) degree from Beijing Medical University and a PhD from Academy of Military Medical Sciences. After eight years as postdoctoral fellow, he served as lecturer and research scientist sequentially in the Second Military Medical University (China) and the University of Iowa. He joined the Shandong Academy of Medical Sciences in 2004 and moved to Soochow University in 2013 and to Xiamen University in 2019. He works in the field of basic medical sciences including immunology, experimental hematology, molecular biology, and their applications in defining the pathogenesis of various diseases.
Prof Suleyman Aydin has received his PhD in Illinois Institute of Technology during the period of 1999. Currently, he is working at Medical School as Professor of Medical Biohemistry in Firat University. He has authored more than 175 research articles/books. He is currently also serving as scientific Reviewer for various academic journals He is a member of Organization Committee Members, Council Members,, The American Turkish Society, Turkish Biochemical Society and The Endocrine Society). He has honoured as Certificate in Laboratory Animal Science, Good Clinical Practice (GCP) and statistics, Certificate in Clinical Trial, Trainer’s Training Certificate and Pedagogical Formation Training Certificate.
Dr. Azar is a board-certified ophthalmologist, Dean of the University of Illinois College of Medicine, and Professor of Ophthalmology, Bioengineering and Pharmacology. His prior positions include tenured professor of ophthalmology at Harvard Medical School, director of the cornea service at Massachusetts Eye and Ear Infirmary, senior scientist at Schepens Eye Research Institute, and faculty member at Johns Hopkins School of Medicine. He earned an executive MBA from the University of Chicago. His basic science and clinically related vision research has contributed significantly to advances in the treatment of corneal diseases and in refractive surgery. He has authored >400 scientific articles and book chapters, is an editor of 16 books in ophthalmology, and holds 32 patents.
Dr. Raghuvir K. Arni is a Full Professor at the Department of Physics and Director of the Multiuser Center for Biomolecular Innovation, São Paulo State University, Brazil (www.cmib-unesp.com). He obtained his PhD in protein crystallography from the Free University/Technical University Berlin was a research associate at the European Molecular Biology Laboratory, Heidelberg and a visiting professor at Michigan State University. His research focus is centered on the three-dimensional structures of proteins, primarily plant, animal and bacterial toxins and enzymes involved in blood coagulation. He is the author of over 130 scientific publications.
Professor Abell graduated from the University of Adelaide with BSc(Hon) and PhD and then undertook a postdoctoral fellowship at the University of Cambridge. He held a professorship at the University of Canterbury before returning to the University of Adelaide in 2007, where he is currently the professor of Chemistry and node director of the ARC Centre of Excellence for Nanoscale Biophotonics. In Adelaide he co-founded an Adelaide-based company (Calpain Therapeutics) to develop macrocyclic protease inhibitors as a potential treatment for cataract and other conditions. He was the Past Head of School of Chemistry and Physics at the University of Adelaide and recent recipient of the Royal Australian Chemical Institute Adrien Albert Prize and the Alexander R. Matzuk Prize and Lecture in Drug Discovery Baylor College of Medicine, Houston.
Yusuf Akhter has received PhD from the University of Hyderabad, India in 2010. He worked as DAAD and EMBO long term fellow at the European Molecular Biology Laboratory, Germany. Currently, he works as Assistant Professor at Centre for Computational Biology and Bioinformatics, Central University of Himachal Pradesh, India. His research group is mainly using structural bioinformatics approaches for drug discovery against microbial pathogens, understanding functions from protein structures and immunoinformatics. He serves as Associate Editor in several other reputed journals also like BMC Microbiology, Archives of Microbiology and Cogent Biology.
Anupam Bandyopadhyay completed M.Sc. in Chemistry from Banaras Hindu University in 2007. After a short period of R&D job, he completed Ph.D. degree from IISER-Pune in 2012 under the supervision of Prof. H. N. Gopi. To gain better proficiency in biochemistry and chemical biology, he joined Boston College as a Postdoctoral Fellow in 2013 with Prof. Jianmin Gao and later in 2016 with Prof. Bradley Pentelute’s lab at MIT. He returned to India in 2018 for a short period of bridging postdoc position with Prof. Balram’s group at NCBS-TIFR, and since January 2019 he is appointed as an Assistant Professor at the Indian Institute of Technology, Ropar, India. His current research includes engineering peptides for disease-related biomolecule recognition pertained to diagnostics and therapeutics discovery.
Dr. Biswanath Bhunia received a PhD in 2012 from National Institute of Technology Durgapur’s Biotechnology Program. Following completion of his PhD, Dr. Bhunia joined to academia as a tenure-track Assistant Professor within the Department of Bioengineering at the National Institute of Technology Agartala in 2013. Dr. Bhunia is working on various secondary metabolite production using fungal, bacteria, cyanobacteria, algae etc. He has authored or co-authored 60 peer-reviewed papers, ten book chapter, and presented at numerous national and international conference on topics ranging from bioprocess engineering, bioinformatics, enzyme and microbial technology, advanced purification process and modelling. Dr. Bhunia’ teaching interests are focused on Bioprocess Engineering, Environmental Biotechnology, and Bioinformatics.
Dr. Banerjee did Bachelor’s with Chemistry Honors from Barasat Government College. master’s in Biophysics and Molecular Biology from Razabazar Science College under Calcutta University, Kolkata, India. He joined the Laboratory of Professor Siddhartha Roay, Bose Institute, Kolkata and awarded Ph. D. degree in 2003. He joined Indian Association for the Cultivation of Science before moving to Kalyani University in 2004. In 2005, He the joined Department of Biotechnology and Dr. B. C. Guha Centre for Genetic Engineering and Biotechnology and continue research on structure-function relations ion of aminoacyl-tRNA synthetases. In 2014, I received JSPS fellowship for faculties and spent eight months in Tokyo Institute of Technology, Japan in the laboratory of Dr. Daisuke Kiga.
Dr. Attila Borics received his Ph. D. in 2005 from Creighton University (USA) in the field of chiroptical spectroscopy and conformational studies of peptides. Then he joined the Biological Research Centre of the Hungarian Academy of Sciences in Szeged (Hungary) as a research associate. His research focuses on biomolecular structure, more specifically, the atomic level structural investigation of the activation mechanism of G protein-coupled receptors. Dr. Borics is also an adjunct lecturer in the Department of Biochemistry and Molecular Biology.
Dr. Breydo obtained a Ph.D. in Chemistry from the University of Missouri, Columbia. Currently, Dr. Breydo is a Research Associate at the University of South Florida. He has published more than 70 scientific publications. He is also an Associate Editor of Biochemical and Biophysical Reports and editorial board member of several journals including Protein and Peptide Letters.
Sanghamitra Bandyopadhyay obtained a doctorate (Ph.D.) in Computer Science from the Indian Statistical Institute. She holds an M. Tech in Computer Science from Indian Institute of Technology, Kharagpur. She is currently the Director of Indian Statistical Institute when she also holds the position of a full Professor. She has published more than 250 scientific publications and is an Associate Editor of Biosciences and IEEE Transactions on Systems, Man and Cybernetics: Systems. She has received several awards and honors, including the Shanti Swarup Bhatnagar Prize, the most coveted scientific prize in India.
Dr. Cilli obtained a doctorate (Ph.D.) in Molecular Biology (Biophysics) from the Federal University of Sao Paulo, Brazil. Dr. Cilli is Adjunct Professor and Vice-Director of Institute of Chemistry (Unesp – Univ. Estadual Paulista, Brazil). Currently, Dr. Cilli is a researcher at CEPID Center for Innovation in Biodiversity and Drug Discovery, Nanobionics and the Synthesis, Structure and Applications of Peptides and Proteins research groups. During his career, Dr. Cilli has authored more than 80 manuscripts and patents. The studies by Dr. Cilli’s group are highly multidisciplinary, involving organic synthesis, biophysical evaluation, bioanalytical approach and cell biology.
Dr. Norelle Daly obtained a Doctorate in Biochemistry from The University of Queensland, Brisbane. Her research involves the use of NMR spectroscopy to study peptides with therapeutic potential, and she has been centrally involved in determining the structures of more than 50 cysteine-rich peptides including peptides isolated from plants, cone-snails, bacteria, spiders and frogs. She has authored more than 150 manuscripts and is an inventor on three patents. Currently, she is a Professor at James Cook University, Cairns where her research focuses on peptides involved in anti-inflammatory diseases and wound healing.
Dr. D’Auria is the Director at the Institute of Food Science, CNR, Avellino, and an Associated Professor at INRS, Laval, Canada. He also heads the Laboratory of Protein Biophysics and Biosensor Development at ISA-CNR, Avellino, Italy. The main interests of Dr. D’Auria Lab are focused on the design and realization of advanced bio/sensors for safety and security. Dr. D’Auria has authored more than 200 publications on international journals and several national and international patents.
Prof. Ming Du has published more than 160 peer-reviewed journal articles, including the articles in Nature Communications, Trends in Analytical Chemistry, Critical Reviews in Food Science and Nutrition, Journal of Agricultural and Food Chemistry, etc. Besides, he contributed 12 Books and Chapters focusing on the field of Functional Proteins and Peptides. His research activities are in the areas of (1) Structure-Activity Relationship of Proteins and Peptides; (2) Mechanism of Bioactive Proteins (Peptides) on Osteoporosis, Thrombosis, Hypertension, etc.; (3) Modification and Utilization of Food-derived Proteins by Physical Processing or Enzymatic Hydrolysis.
Cell surface glycoprotein, such as human transferrin receptor was biochemically analyzed, the structure of N-linked & O-linked oligosaccharides was investigated, and the specific location of single O-linked oligosaccharide was found. Biological analyses of nuclear & cytosolic O-GlcNAc, and OGT enzyme have been performed to identify cellular function of sugar residues on polypeptide backbone.Regulation of OGT enzyme activity via posttranslational modifications, such as S-nitrosylation & S-denitrosylation have been characterized in innate immune system and Alzheimer’s Disease.
Dr. Swagata Dasgupta is a Professor of Chemistry at the Indian Institute of Technology Kharagpur, India. She completed her Ph.D. from Rensselaer Polytechnic Institute, USA. Her research interests in protein chemistry involve protein–protein and protein-small molecule interactions and protein structure analyses. She has contributed to teaching and research at IIT Kharagpur for the past 20 years and has over 100 publications. Her pioneering work has been on polyphenols and their interactions with biomacromolecules. Recent work on fibrillation of proteins has been initiated to study amyloid fibrils, the hallmark of neurodegenerative diseases. The unique feature of her work is the blend of experimental protein chemistry with in-depth structural analysis.
Dr. Dubey obtained Ph.D. degree in Molecular Biology from Banaras Hindu University, Varanasi, India. After his postdoctoral training at Florida State University, USA, he joined Indian Institute of Technology Guwahati, India as Assistant Professor. Currently Dr. Dubey is full Professor at Indian Institute of Technology Guwahati, India. He has published more than 100 scientific publications and is a named inventor of 07 issued U.S patents. Dr. Dubey has done extensive studies on Biochemistry of Leishmania parasite. Dr. Dubey has likewise made cutting edge contributions to understanding protein folding.
Professor Salvatore Foti graduated from the University of Catania followed by postdoctoral research from the Institute of Organic Chemistry, University of Mainz, Germany, and from the Chemistry Laboratory of the University of Cambridge UK. He is currently a Professor of Chemistry and head of the Proteomic Platform of the Bio-nanotech Research and Innovation Tower at the University of Catania. His research interest involves the use of mass spectrometry-based proteomic techniques for protein characterization. Recent applications include proteins from wheat kernel, milk and mitochondrial membrane. He is the author of over 120 scientific publications and book chapters.
Prof. Dr Octavio Luiz Franco is graduated in Biological Sciences from the Universidade Federal do Ceara´ (1998) and obtained his PhD in Biochemistry and Molecular Biology from the Universidade de Brasılia (2001). He is the head professor at the Universidade Catolica Dom Bosco and the Universidade Catolica de Brasilia, a visiting professor at the Universidade Federal de Juiz de Fora, a researcher at the Post- Graduation program of Physics Education from UCB, a researcher at the Universidade de Brasilia in the program of Molecular Pathology and researcher at the CNPq. He has experience in biochemistry, proteomics and molecular modeling. He currently works on the following subjects: antimicrobial peptides, immunomodulators, antifreezing and proteome of animals, plants and microorganisms. His work has also been focused on the development of bioproducts and bioprocesses. Currently, he has more than 250 manuscripts already published.
He is now a Professor in Zhengzhou University of School of Life Sciences. He obtained doctorate (Ph.D.) of biochemistry and molecular biology in Lanzhou University, and had been a visiting scholar at The University of Chicago Pritzker School of Medicine. He works on cancer immunology and immunotherapy, and has published more than 50 scientific papers and he is an inventor of 21 issued China patents. He also acquired several honors, such as Young Peptide Scientist Award from Chinese International Peptide Syposium, Outstanding Young Scientist Award from Chinese Society for Immunology, and Young Scientist Excellent Presentation Award from Chinese Society for Medicinal Chemistry.
Ehud Gazit is a Professor and Endowed Chair at Tel Aviv University. From 2008-2012, he served as Tel Aviv University Vice President for Research and Development. He did B.Sc. (summa cum laude) at the Special Program for Outstanding Students, Tel Aviv University and his Ph.D. with highest distinction from the Weizmann Institute of Science in 1997. He is a faculty member at Tel Aviv University since 2000, after completing his postdoc at MIT. Professor Gazit received numerous awards and honors including Hesterin Award and Kadar Family Award. He is a fellow of the Royal Society of Chemistry and member of EMBO. In 2015, he was knighted by the Italian Republic.
Dr. Holub is an Assistant Professor of Biochemistry in the Department of Chemistry and Biochemistry at Ohio University. He has nearly 20 years of experience in the development and discovery of peptide and protein-based therapeutics. Professor Holub received his Ph.D. in biomolecular chemistry from New York University in 2009 where he developed unique bioconjugation reactions to functionalize peptidomimetic scaffolds. Following completion of his Ph.D., Dr. Holub went on to perform post-doctoral research at Yale University. While at Yale, Dr. Holub developed high throughput screens to quantify the cytosolic delivery of peptides and miniature proteins to enhance their therapeutic potential. Upon completion of his post-doctoral appointment, Professor Holub joined the faculty of Ohio University where his current research involves the development of biomimetic miniature proteins to study the fundamental nature of therapeutically relevant protein-protein interactions. Dr. Holub has published over 20 research articles and holds two US patents from his work in the field.
Kai Hilpert is an associate Professor (Reader) of Infection and Immunity at the Institute of Infection and Immunity at St. George’s University of London. He has 20 years of experience in the synthesis of peptide libraries, screening and optimization of peptides. Since 2003, he works on the design and optimization of short antimicrobial peptides. He has been working close with the industry and for the last two years is a founder and director of a university spin-off company TiKa Diagnostics Ltd. that exploits synthetic peptides developed in his laboratory. He has co-organized the International Meeting on Antimicrobial Peptides (IMAP) in London (twice), Leipzig and Graz. In addition, he is co-author of the article "Alternatives to antibiotics--a pipeline portfolio review " published in Lancet Infectious Diseases that won the Elsevier Atlas award. In the last years, he has intensively worked on optimizing peptide libraries against multidrug-resistant bacteria, mainly Pseudomonas aeruginosa, Staphylococcus aureus and Mycobacterium tuberculosis.
Dr. Hong-Yu Hu earned his Ph.D. degree in biochemistry from Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, in 1993. He then completed his postdoctoral research at Hong Kong University of Science and Technology during 1994-1996., He became a visiting scholar in the Department of Biochemistry, University of Connecticut Health Center in 2000. He then joined the Shanghai institutes for Biological Sciences, then he joined the CAS Center for Excellence in Molecular Cell Science, as a research professor and principal investigator. His research focuses on protein aggregation and cellular homeostasis. His research group attempts to elucidate the molecular mechanisms underlying misfolding and amyloidogenic aggregation of the neurodegenerative disease-related proteins and their biological effects.
Doctor Paola Irato graduated in Biological Sciences from the University of Milan in 1984. In 1988, she obtained the research doctorate in Evolutionary Biology from University of Padua. Since 1991, she has been a researcher of general physiology. Dr. Irato has always been interested in heavy metal detoxification systems. She has been in-charge of the project “The determination of biological stress indices in mugilidae from high and low anthropic stress brackish environments”.
Dr. Reza Khodarahmi is a Professor in Biochemistry. . He received his BSc degree in general Biology from the Razi University-Kermanshah and then graduated in Biochemistry (MSc) from the Tarbiat Modarres University-Tehran. He received his PhD in 2005 from the Institute of Biochemistry and Biophysics, University of Tehran for his studies on the effects of artificial chaperones on protein misfolding and aggregation. Since 2007, he has held a position in the school of Pharmaceutical Sciences, Kermanshah University of Medical Sciences. His research interests focus on the in vitro characterization of oxidative events accompanying amyloid aggregation, drug-protein interaction and enzyme inhibition, using both experimental and computational tools.
Dr. Kukol obtained his PhD in Biophysical Chemistry from the University of Bielefeld, Germany, followed by postdoctoral research in the Department of Biochemistry, University of Cambridge, UK. Then he became a Lecturer at the Department of Biological Sciences, University of Warwick. Currently, he is a Principal Lecturer at the School of Life and Medical Sciences, University of Hertfordshire, UK. He has published more than 40 journal articles and book chapters, including a student textbook about enzyme kinetics. Dr. Kukol's research interests include antiviral drug discovery, cardiac transmembrane protein-protein interactions and protein-protein interactions in plant-pathogen systems, using molecular modelling, biophysical and bioinformatics techniques.
Prof. Nand Kishore is Professor at the Department of Chemistry, Indian Institute of Technology Bombay. After completing PhD from Indian Institute of Technology Delhi, he received postdoctoral training at Yale University, and National Institute of Standards and Technology, U.S.A. His research interests include understanding physical chemistry underlying biologically important systems which have contributed to thermodynamic characterization of protein folding intermediates, drug-protein interactions, drug partitioning in delivery vehicles, protein-solvent interactions, and prevention of aggregation/fibrillation of proteins by using a combination of calorimetric and spectroscopic techniques. He has published about 100 papers in the areas of Physical Chemistry, Biophysical Chemistry and Biochemistry.
Mahesh Kulkarni is a Scientist at Biochemical Science Division at CSIR-National Chemical Laboratory. His research group is involved in characterization of Advanced glycation end products in diabetes using proteomic approaches and investigate their role in pathogenesis of diabetes and its complications. The long-term goal is to identify diagnostic markers for various diabetic complications, identify drug targets and develop intervention strategies.
Setsuko Komatsu is a Chief of Field Omics Research Unit at National Institute of Crop Science and a Professor at the University of Tsukuba, Japan. She is employed at Meiji Pharmaceutical University and then also at Keio University School of Medicine. Since 1990, she is working on plant proteomics using protein sequencer and mass spectrometry. Her main research interests are within the field of crop proteomics, biochemistry and molecular biology with a special focus on signal transduction in cell. She has authored more than 300 manuscripts on plant omics research.
Dr. Shufang Liang obtained a Ph.D degree in Biochemistry and Molecular Biology from the Sichuan University of China in 2003, and worked as a postdoctoral fellow at Fudan University of China from 2003 to 2005. She is a full professor of Biochemistry and Molecular Biology at Sichuan University since 2010. Her study focuses on (1) cancer biology,(2)exploring new biological functions and pharmaceutical roles of proteins / peptides, (3) identification of novel disease biomarkers and drug targets mainly using proteomics-based systems technology. She has published 50 peer-reviewed scientific papers by now.
Dr. Nikolaos Labrou received his BSc degree in Chemistry from the University of Patras, Greece (1987-1991) and his PhD in Enzyme Biotechnology from the Agricultural University of Athens (1992-1996). He has conducted postdoctoral research, as Marie Curie fellow, in Leeds UK (1996-1998) and then at Agricultural University of Athens (1998-2001). Dr Labrou started his career as Assistant Professor (2002) and he is currently full Professor with tenure and Director of the Enzyme Technology Lab at the Department of Biotechnology, Agricultural University of Athens. He has authored more than 115 peer-reviewed articles in leading international journals, 26 book chapters and he has edited two books. His research covers many areas of biotechnology including enzyme and protein engineering, immobilised enzymes, biosensors, drug design, protein downstream processing, microalgae technology as well as the characterization of therapeutic enzymes, proteins and other biomolecules.
Dr. Lovas obtained his formal training in chemistry in Hungary at the József Attila University and the Biological Research Center of the Hungarian Academy of Sciences, Szeged. In 1990, he joined Creighton University where he is a Professor of Biomedical Sciences. His research deals with conformation-biological activity relationships of polypeptides and description of solution structure of polypeptides by molecular dynamics simulations, ab initio quantum chemical calculations and chiroptical spectroscopy. He has published over 140 scientific publications.
Dr. Sridhar Muthusami completed his Ph.D in endocrinology in the year 2011 from the University of Madras, India. His doctoral study was aimed at delineating the molecular mechanism underlying the anabolic actions of Cissus quadrangularis, an indigenous herb believed to exert anabolic effects on bone cells through IGFR. In addition, he has worked on the role of thyroid stimulating hormone (peptide hormone) on the regulation of IGFR in osetoblastic SaOS-2 cells. After completing his Ph.D, he has joined for his Postdoctoral work in the department of Radiation Oncology, Chungbuk National University, South Korea. He has worked on the role of Epidermal growth factor/receptor (EGF/EGFR) signaling and its regulation of oncoprotein Fused Toes Homolog (FTS) in cervical cancer cells from 2011 to 2014. Since 2015, he moved to the department of biochemistry, Karpagam Academy of Higher Education (Deemed to be University) as Associate Professor and working in the area of Polycystic ovarian syndrome and cancer biology.
Associate Professor Martin gained her PhD in Chemistry from The Australian National University. She obtained the Alexander von Humboldt and Fulbright awards to undertake post-doctoral stays in Germany and USA, respectively, before her first academic position at The Flinders University of South Australia. She currently holds a position at Monash University (since 2003) where she has a research focus on the electrochemistry of cytochrome P450 enzymes involved in steroid biosynthesis, membrane action of antimicrobial and amyloidogenic peptides and incorporation of biomolecules into novel materials especially those with semiconducting properties.
Dr. Di Maro obtained his PhD in Molecular Systematic at the University "Federico II", Naples, Italy. Currently Dr. Di Maro is Associate Professor in Biochemistry at the Second University of Naples, Caserta (Italy). He published more than 100 scientific papers covering several fields. The area of interest of Dr. Di Maro is focused on Biochemistry, Molecular Biology and Biological Sciences. In particular, the main focus of his researches is aimed at clarifying the structure/function relationship of proteins.
Dr. Macedo obtained her doctorate (Ph.D.) in Biological Sciences from the Escola Paulista de Medicina-UNIFESP. Currently, Dr. Macedo is full professor at the Universidade Federal de Mato Grosso do Sul-UFMS, where she purifies insecticide and antibacterial compounds from diverse sources, among these are peptidase inhibitors, lectins and antimicrobial peptides.
Dr. Matsushima completed his doctorate in polymer physics at Hokkaido University. After that, he joined Hokkaido Institute of Technology in 1980-1983 and Sapporo Medical University from 1983-2013. In 1986-1988 he joined the University of Virginia, USA, as the visiting associate professor. Now he is the head of Institute of Tandem Repeats. He has studied the structure, evolution, and function of tandem repeats including leucine-rich repeats by bioinformatics and their solution structures by nuclear magnetic resonance and small-angle x-ray scattering. He has published more than 90 scientific publications. He is the editorial board member of Annals of Virology and Research.
Dr. Ujjwal Maulik is a Professor and Head of the Department of Computer Science and Engineering, Jadavpur University, Kolkata, India. He did his Bachelors in Physics and Computer Science in 1986 and 1989, respectively. Subsequently, he did his Masters and Ph.D. in Computer Science in 1992 and 1997, respectively. Dr. Maulik has worked in a number of universities and and research institutes in the USA, Australia, Germany, China, Italy, France, Poland, Hungary and Slovenia. He has co-authored 7 books and more than 300 research publications.
Dr. Adriano Mollica is an Associate Professor of Medicinal Chemistry at the Univ. “G. d’ Annunzio” of Chieti-Pescara, Italy and PhD in “Pharmaceutical Sciences”. From 2013, he is board member of the PhD program “Biomol. and Pharm. Sciences” and Tutor of several PhD students and Post-doctoral fellows. His research interests are focused on opioid peptides, neurodegeneration, treatment of chronic and neuropathic pain, multi-target compounds and nutraceuticals. He is a co-author of 82 papers published in international journals, one European Patent and one Italian Patent. He is currently “Editor in Chief” of “Current Bioactive Compounds”, and editorial board member of Mini rev. in Org. Chem. and of Prot. & Pept. Lett.
Hidehito Mukai received his Ph.D. degree in Applied Biochemistry from the University of Tsukuba in 1990. After a postdoctoral fellowship from the University of Texas Southwestern Medical Center at Dallas he advanced his career by working at the University of Tsukuba, NEDO Project of MITI, Mitsubishi Kagaku Institute of Life Sciences, and Kyoto Pharmaceutical University. He is now Principal Investigator of Laboratory of Peptide Science and Associate Professor of Graduate School of Bioscience, Nagahama Institute of Bio-Science and Technology from 2011. His main research interests are the physiological and pathophysiological roles of "cryptides", novel endogenous regulatory peptides hidden in protein structures, and their "accumulative" signaling mechanisms.
Dr. Oliveira obtained a doctorate (Ph.D.) in Biochemistry from the University of Aberdeen, Aberdeen, Scotland. Currently Dr. Oliveira is a Titular Professor at the Federal University of Ceará, Brazil. He has published more than 120 scientific publications and has been working with proteins and pathways involved with plant defense against pathogens.
Dr. Permyakov obtained a doctorate (Ph.D.) in physics and mathematics from the Moscow Institute of Physics and Technology and defended a doctor dissertation in biology in Moscow State University. Previously, he worked at the Institute of Theoretical and Experimental Biophysics (Russia) and the Ohio State University (USA). Currently, Dr. Permyakov is the Director of the Institute for Biological Instrumentation (Russia). He has published 10 monographs and more than 160 articles.
Professor David Andrew Phoenix, OBE, FAcSS, DSc has held visiting chairs in Canada, China, UK and Russia. He has over 250 publications focused on the structure function relationships of bioactive amphiphilic molecules and was awarded a higher doctorate by Liverpool University for his impact on the field. He is a Fellow of the Royal Society of Chemistry, The Society of Biology, The Institute of Mathematics and its Applications and the Royal Society of Medicine. He was elected to Fellowship of the Royal College of Physicians Edinburgh for his contribution to medical research and education, made an Officer of the Most Excellent Order of the British Empire for services to Science and Higher Education and recognized as an Academician by the Academy of Social Sciences. He received individual Excellence award by China’s Vice Premier and was admitted to Order of Friendship (China) for outstanding contribution to the country’s economic and social development.
Dr. Papageorgiou graduated from the University of Athens with a BSc degree in Chemistry (1979-1984) and carried out his PhD at the National Hellenic Research Foundation (1987-1991). He was a recipient of a post-doctoral fellowship (1992-1994) from AstraZeneca and worked at the University of Oxford, Laboratory of Molecular Biophysics. He continued his post-doctoral training as a research officer at the University of Bath. In 2000, he moved to Finland as Head of the Protein Crystallography Core Facility at the Turku Centre for Biotechnology and he is currently Principal Investigator and Adjunct Professor in Biochemistry and Structural Biology at the University of Turku. He has authored more than 90 scientific papers.
Dr Marc-Antoine Sani is a research fellow at the School of Chemistry, Bio21 Institute, The University of Melbourne. His expertise are focused around DNP NMR and solid-state NMR, with a particular focus on in-cell studies of membrane-active peptides and proteins. He has published over 60 publications with over 1200 citations. He is an editorial board member of ANZMAGazine, Bio-protocol and the Victorian representative for the Australian Society for Biophysics.
Dr. Divakar Sharma did M.Sc. in Biotechnology in 2009 from C.S.J.M. University, Kanpur, India and Ph.D. in Biotechnology in 2015 from Jiwaji University, Gwalior, India. He has a vast research experience and has numerous publication to his credit.
Dr. Laishram R. Singh is presently working as an Assistant Professor at the University of Delhi. Dr. Singh is a well-known enzymologist and protein biochemist with 15 years of research experience. He has published more than 40 publications in many esteemed journals in the field of proteostatic regulation and protein covalent modification by homocysteine. He has also edited books and authored several chapters in many books published by Springer, InTech and Elsevier etc. Currently Dr. Singh’s research group is interested in developing strategies to remove toxic protein deposits in neuronal cells and cardiomyocytes using proteostatic modulators and small molecule compounds.
Prof. P. Shukla is working as Professor and Head of the Department of Microbiology at Maharshi Dayanand University, Rohtak, India. Prof. Shukla was also awarded with Indo-USA Professorship by American Society of Microbiology at University of Cincinnati, USA. His current research interests are in the fields of enzyme technology, protein bioinformatics and microbial biotechnology. Prof. Shukla has written five books, twentytwo book chapters, one patent and have published more than 61 papers in peer reviewed reputed international journals. He received several awards, including Received ‘Prof. S.B. Saksena, Award’ in life sciences (1999), Danisco India Award in Probiotics & Enzyme Technology (2010), AMI-Alembic Award 2015 etc. He is also working as General Secretary, Association of Microbiologists of India (AMI) a premier scientific society in Asia.
Dr. Nandini Sarkar completed Ph.D in Biotechnology from Indian Institute of Technology Guwahati, India in 2011. Currently, she is working as Assistant Professor in the Department of Biotechnology and Medical Engineering in National Institute of Technology Rourkela, India. Her research involves studies on protein amyloidogenesis and identification of potential anti-amyloidogenic agents. She is also interested in mutagenesis studies on physiologically important proteins.
Dr. Kazuyasu Sakaguchi received his Ph.D. in Biochemistry at Kyushu University, Japan in 1989. In 1989, he joined a group of Dr. Ettore Appella at National Institutes of Health, National Cancer Institute, USA. From 1989 to 1999, he was a postdoctoral fellow, associate fellow, and staff scientist at the NIH. He moved to Kyushu University as an Associate Professor in 1999. In 2003, he joined the Department of Chemistry, Hokkaido University as a full professor. His recent research has focused on structure and function of tumor suppressor protein p53, especially the tetramer formation of p53, and function and regulation of oncogenic protein phosphatase PPM1D. His research interest also includes development of functionalized nanowire based on self-assembly of modified amyloid peptides. Dr. Sakaguchi has published more than 130 articles, his total citations are over 13,000 and h-index is 52.
Maria Staiano obtained the Ph.D. in Cell Biology and Physiopathology at the University of Siena, Italy. Actually, she is a scientist with a tenured position at National Research Council of Italy (CNR), Institute of Food Science (CNR), Italy. Her research interests are focused on the study of protein-protein interactions and on protein manipulation for advanced biotechnological applications. She is author of almost 100 publications on international journals.
Dr. Darko Stevanovic is assistant professor in Medical Physiology at the School of Medicine, University of Belgrade, Serbia and research fellow at Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. His research focuses on the role of regulatory peptides, neuropeptides and hormones in central and peripheral energy balance regulation. He received his PhD degree (2010) at Belgrade University, where he examined the role of inflammatory modulators in anorexia and obesity and their role in pathophysiology of metabolic imbalances. He received two fellowships from German Academic Exchange Service – DAAD (University of Tubingen, 2002, and German Institute for Human Nutrition, Berlin/Potsdam, 2008), European Society of Endocrinology Fellowship (Erasmus University, Rotterdam, The Netherlands, 2011/12), City of Belgrade Award for best young scientist (2003) and joint award from Endocrine Society (USA) and European Society of Endocrinology for outstanding achievements in endocrinology in 2010 and 2011. Since 2013, he is conducting research at the Center for Life Sciences, Harvard Medical School, where he focuses on role of sugars in feeding behavior, thermosensation and central FGF21 signaling in stimulation of energy expenditure. He is a member of Endocrine Society (USA), American Diabetes Association and European Society of Endocrinology. In the last 10 years, he has published more than 20 original research articles.
Bart De Spiegeleer studied pharmaceutical sciences from the Ghent University, where he completed his Ph.D. on anticancer platinum complexes in 1989. He continued to work in the pharmaceutical industry and was a board member of several start-up companies. Returning to Ghent University, he became full-time professor in 2008, heading the EU-GMP approved Drug Quality and Registration (DruQuaR) laboratory at the Faculty of Pharmaceutical Sciences. His main current scientific interests include regulatory and functional quality aspects of medicinal products with emphasis on bioactive peptides and proteins, biologics/ATMP and NTD-medicines, using LC-MS/IR/CD/biosensors, biological activity using receptor/cell/tissue/animal models and pharmacokinetics with emphasis on the BBB and dermal/mucosal local permeation using in-vitro and in-vivo models.
Saad Tayyab is working as a Professor of Biochemistry at the Institute of Biological Sciences, University of Malaya, Malaysia since 2004. He obtained B.Sc. (Hons.) Chemistry (1979), M.Sc. Biochemistry (1981), M.Phil. Biochemistry (1983) and Ph.D. Biochemistry (1987) from Aligarh Muslim University, India. He has published more than 100 scientific publications in ISI-indexed journals. He has served as the Editor-in-Chief of the Malaysian Journal of Biochemistry and Molecular Biology (2015-2017). He has been on the editorial board member of the Bioscience Education e Journal, UK (2008–2011) and Indian Journal of Clinical Biochemistry (2002–2004). Currently, he is serving as the editorial board member of Biochemistry Research International (since 2013), and Letters in Drug Design & Discovery (since 2015).
Jin Tao received MD and PhD from the Nanjing Medical University, China in 2012. He worked as Research Fellow at the National University of Singapore and Postdoctoral Research Associate at Washington University School of Medicine, USA. Currently, he works as a full professor in Department of Physiology and Neurobiology, Soochow University, China. He is currently Head of the Department, Vice Dean of School of Basic Medicine, and Director of Centre for Ion Channelopathies in Soochow University. His research group is mainly using electrophysiological recording and biochemical approaches for drug discovery against ion channels, understanding the roles of neuropeptides and ion channels in pain regulation. He is the Editorial Board member of Research Journal of Pharmacology, Stem Cell Discovery, and Protein & Peptide letters.
Chunyan Tan obtained her Ph. D. from the University of Florida in 2004. After one-year postdoctoral training in Joseph T. Hupp’s group at Northwestern University, Chunyan joined the Graduate School at Shenzhen, Tsinghua University in 2005 and worked as a faculty member ever since. Chunyan has published over 50 scientific publications. She serves as a member of the Editorial Advisory Board for Protein & Peptide Letters and ACS Applied Materials & Interfaces.
Dr. Tuffery is a full time researcher and a team leader at INSERM (French Institute for Health). He has obtained a doctorate (Ph.D.) in Biomathematics from the University Paris-Diderot, Paris, and he has over 25 years of experience in structural bioinformatics, a field in which he has authored more than 70 scientific publications. Currently, Dr. Tuffery is the leader of a team focusing on in silico protocols for peptide protein interactions. He is also a member of the board of the French national infrastructure for bioinformatics.
Dr. Vitagliano is a senior scientist and group leader at the Institute of Biostructures and Bioimaging of the Italian National Research Council (CNR) where he held the position of deputy head of the Naples Unit from 2010 to 2013. The research activities of Dr. Vitagliano are focused in the large area of structural characterization of biological macromolecules. He is the (co)author of more than 150 publications, which include 140 papers published in ISI Web journals, and one patent. He has also been an invited speaker in several National and International Meetings, including Gordon and Murnau Conferences. Dr. Vitagliano has been the scientific coordinator of projects funded by regional (Regione Campania), national (Italian MIUR, CNR and ASI), and international (EU) institutions for a total of about three million euros.
Dr. Rui Wang earned his PhD degree in organic chemistry and medicinal chemistry in 1988 from Sino-Japan joint PhD program of Lanzhou University and Kyoto University, Japan. He then worked as a postdoctoral fellow in Lanzhou University and University of Kansas, USA, from 1989 to 1993. He was appointed as a full professor at Lanzhou University in 1994 and named the Cheung Kong Professor of Peptide Pharmaceutical Sciences in 2004. Research Interests: (1) Peptides: Chemistry, Biology and Pharmaceutical Sciences (2) Medicinal Chemistry, Peptide Drugs and Chiral Drugs (3) Chiral Science, Organic Synthesis, Asymmetric Catalysis.
Dr. Wei currently serves as the deputy head in the Department of Bioinformatics and Biostatistics, College of Life Science and Biotechnology, Shanghai Jiaotong University. He is the editor-in-chief of the journal “Interdisciplinary Sciences- Computational Life Sciences”. Prof. Wei’s research is in the general field of bioinformatics with more than 250 journal papers, 9 monographs with 5000 SCI citations and an H factor of 45, made some ground breaking research works in theoretical and molecular simulations of liquids and biological systems.
Jianxi Xiao is a professor at the College of Chemistry and Chemical Engineering, Lanzhou University, China. He obtained Ph. D. from Rutgers University-New Brunswick in 2009, and continued his postdoctoral work there from 2009-2011. He joined the College of Chemistry and Chemical Engineering at Lanzhou University in 2012 and worked as a faculty member ever since. His main interests focus on the bioanalytical and biophysical characterization of proteins and peptides, biomimetic materials, and protein-inorganic hybrid nanomaterials. He has published over 30 scientific publications. He serves as the editorial board member of Protein & Peptide Letters.
Professor Yu is currently a full professor at the College of Biotechnology and Bioengineering, Zhejiang University of Technology, China. He received Ph.D. in Marine Environmental Sciences from the Hong Kong University of Science and Technology in 2007 and did postdoctoral work in the Department of Biomedical Engineering, Boston University from 2008-2010. He joined the Zhejiang University of Technology in 2010. Currently, he is serving as the director in the Department of Biotechnology and Director of the Institute of Microbiology. His lab is most interested in the enzyme engineering and molecular roles of regulator in biosynthesis of microbial active compounds.
Dr. Yu earned his doctor degree (Ph.D.) in Biochemistry and Molecular Biology from Fudan University, Shanghai China and finished his postdoctoral training in Harvard Medical School. Currently, Dr. Yu is the Vice Director of the Key laboratory of Molecular Medicine, the Ministry of Education and a Professor in the Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University. He has worked in R&D of novel therapeutic recombinant proteins and monoclonal antibodies for more than 20 years. Dr. Yu has authored more than 30 manuscripts and 3 patents. He is also editor in a couple of journals in China.
Dr. Zhang obtained his PhD in Chemical Engineering at Iowa State University. Currently, he is a professor in Biological Systems Engineering and a courtesy professor in Chemical Engineering at Virginia Tech. His research focuses on protein expression and purification, and vaccine development against different diseases and psychoactive compounds.
Dr. Guo-Ping Zhou is currently a Distinguished Professor of Gordon Life Science Institute, USA. He is also an Adjunct Professor of several academics in the United States and China. Dr. Zhou received his Ph.D in Biophysics from University of California at Davis, and completed his postdoctoral training at Stanford University and Harvard University, respectively. Dr. Zhou determined the 3D NMR structures of some proteins, protein-DNA complexes, super lipids such as dolichol and other polyisoprenyls, as well as polyisoprenol recognition sequences. Dr. Zhou has successfully introduced the elegant wenxiang diagrams to elucidate the mechanisms of the coiled-coil proteins, protein-lipids, protein-DNA interactions, and prion protein misfolding observed by NMR. Meanwhile, he has also published many papers in Bioinformatics. Dr. Zhou’s current research is focused on investigation into the relationship between the functions and structures of polysialyltransferases. In addition, Dr. Zhou has edited some special issues on structural biology for several influential scientific journals.
Over the past few years, Prof. Zhang Jian has led the team to focus on the studies of drug discovery on target for major human diseases, especially on precise target identification and ‘First-in-class ‘drug discovery based on clinical samples. In the past five years, he opened up a new direction and made a series of new breakthrough in the field of drug discovery. As a corresponding author, he has published more than 70 articles on Nat Chem Biol, Chem Rev, Chem Soc Rev, Am J Hum Genet, Nucleic Acid Res, J Med Chem, Bioinformatics, etc.
Dr. Hong-Yu Zhang is currently a professor and Dean of College of Informatics in Huazhong Agricultural University. He completed his Ph.D. in biophysics at the Institute of Biophysics, Chinese Academy of Sciences in 1997. His research interest focuses on systems biology and chemical biology. Dr. Zhang has published 160+ articles in the related fields. He received Servier Young Investigator Prize from Chinese Pharmacological Society in 1999, Young Investigator Prize in Chemistry from Chinese Chemical Society in 2005 and also for Natural Science Research in 2011 from Ministry of Education, China.
Dr Shyamasri Biswas received her PhD in biotechnology jointly from Banaras Hindu University, Varanasi, India and University of Potsdam, Germany. During her PhD, she received the prestigious DAAD sandwich research fellowship to carry out her PhD work on a collaborative research project in Germany. After her PhD, she was a scientist in several labs in the United States. She has published her research works in numerous prestigious international journals including Nature Structural and Molecular Biology, Biochemistry and Journal of Biological Chemistry to name a few. Dr. Biswas is a contributing editor in Vacuum Advances in Biotechnology for Vacuum Technology & Coating Magazine and writes a monthly column in biotechnology. In addition, she is a reviewer for many biochemistry and biotechnology journals. She gave several invited talks at national and international meetings in Biotechnology. Presently, Dr Biswas is the owner/ Chairman of a startup company (USA PRIME BIOTECH. LLC), registered in the state of Florida.
Bruno Casciaro graduated in 2013 in Pharmaceutical Biotechnologies with honors at Sapienza University of Rome and received his PhD in Biochemistry in 2017 with a thesis entitled “Different approaches to optimize the antimicrobial properties of cationic peptides: substitution by non-coded amino acids and conjugation to nanoparticles”. His current research is focused on the characterization of the biological properties of natural bioactive compounds, in particular antimicrobial peptides and therapeutic proteins, and on different approaches to conjugate them to nanoparticle systems.
Ebru Çetin is currently an Associate Professor in the Physiology Department at the Faculty of Veterinary Medicine, Erciyes University. From 2000 to 2005, she worked as a Research Assistant of Physiology at The Faculty of Veterinary Medicine, Ankara University. She received her Ph.D. from the University of Ankara in 2005. She is a member of The Turkish Society of Physiological Science. From 2006 to 2013, she worked as an Assistant Professor of the Physiology Department at the Faculty of Veterinary Medicine, Erciyes University. Her research interests include oxidative stress, antioxidant, ghrelin, cardiovascular dysfunction, hepatic dysfunction, hematology, immunity, nutritional physiology, and food additives.
Dr. Kalyan Sundar Ghosh is presently working as an Assistant Professor (Grade-I) in the Department of Chemistry, NIT Hamirpur, India. He completed his Ph.D. from IIT Kharagpur, India and then worked as a Postdoctoral Associate at the University of Maryland, College Park, USA and State University of New York, Albany, USA. His current research interests broadly include protein aggregation and its inhibition using synthetic and natural molecules. He has published 38 research articles in international journals with repute and some of his publications had crossed more than hundred citations each. Recently his group has also started working on bionanomaterials and their applications.
Dr. Subrota Hati obtained B. Tech in Dairy Technology from West Bengal University of Animal and Fishery Sciences, Kolkata (2002-2006). M.Sc. from National Dairy Research Institute, Karnal in the field of Dairy Microbiology (2006-2008) and was also awarded Doctorate Degree from National Dairy Research Institute, Karnal in Dairy Microbiology (2008-2012). Dr. Hati recently completed his post-doctoral study from The University of Queensland, School of Agriculture and Food Sciences, Australia under the Indo-Australia career Boosting Gold Fellowship sponsored by Department of Biotechnology, New Delhi (2018). At present, he is working as Assistant Professor in the Department of Dairy Microbiology, SMC College of Dairy Science, Anand Agricultural University, Anand, Gujarat, India. Dr. Hati is a recipient of numerous prestigious awards which include Prof. Sukumer De Gold Medal from WBUAFS, Kolkata as University Topper (2006), Urmilabala Gold Medal from Indian Dairy Asso., New Delhi, Early Career Research Award by DST, New Delhi, IACBGF-2018 by DBT, New Delhi, INSA Visiting Scientist Award-2018 by INSA, New Delhi. He also visited the University of Copenhagen, Denmark for presenting the research work under Indo-Danish Collaborative workshop-2018.
Dr. Theam Soon Lim received his doctorate from Freie Universität Berlin (Germany) in 2009. He spent time at Max Planck Institute for Molecular Genetics working on recombinant human moncolonal antibody generation. He is currently an associate professor at the Institute for Research in Molecular Medicine in Universiti Sains Malaysia. His work includes academic and industrial based research. His research interests lie in the field of antibody engineering with a focus on recombinant antibody technologies for diagnostic and therapeutic applications.
Dr. Pandey received Ph.D. degree in Biotechnology from Department of Biochemistry University of Lucknow, Lucknow, India under the supervision of Prof. U. N. Dwivedi. After Ph.D. he has worked in CSIR-CIMAP as DST SERB Young Scientist from 2015-2018. Currently, he joined Department of Biochemistry, University of Lucknow as CSIR Senior Research Associate under CSIR Pool Scientist’s Scheme. His research area of interest is Enzymology, Genetic engineering, Bioinformatics etc. He has contributed 40 research papers / reviews and two book chapters.
Dr Surajit Rakshit received PhD in Chemistry from the Jadavpur University, India in 2014 and did postdoctoral work at the Institute of Basic Science , South Korea from 2014-17. He joined the Department of Chemistry, Vijaygarh Jyotish Ray College, Calcutta University in June 2017 as an assistant professor and in October 2017, he moved to the Department of Chemistry, Institute of Science, Banaras Hindu University, India. His current research interests lie in the field of biophysical chemistry with a focus on ultrafast spectroscopic studies of disordered proteins to study the fundamental nature of therapeutically relevant protein structure, function and dynamics.
Dr. Haixia Yang received her Ph.D. in Food Science College from China Agricultural University in 2011. She had been an associate professor in Nutrition Department in Xi’an Jiaotong University in 2016. After that, she studied as a postdoc research fellow in University of Massachusetts Amherst for 2 years and now she is working in Pathology Department from Harvard Medical School. She has published more than 50 papers related to the food science field, such as protein purification and function, phytochemicals and inflammation-associated diseases and cancer.
Dr Giuseppe Grande is MD, Endocrinologist and Ph.D. in “Sciences of nutrition, metabolism, aging and gender disease”. He has attended the 2nd level master in “Andrology and Reproductive Medicine” and the post-graduate courses in "Reproductive andrology", "Andrology and Reproductive Medicine" and in "New technologies in molecular medicine”. Dr. Grande works at the Fondazione Policlinico “A. Gemelli” IRCCS, Rome at the International Scientific Institute (ISI) for the study of human fertility and infertility. He is author of 27 scientific papers in peer-reviewed international journals. His research activity is focused in studying the translational applications of clinical proteomics in endocrinology and in reproduction.
Dr. Muhammad Sarwar Khan has a vibrant career in agriculture, education, and biotechnology and has earned his PhD from the University of Cambridge, UK. The Rockefeller Foundation awarded him a prestigious fellowship under the Rice Biotechnology Program for Developing Countries to research at the Waksman Institute of Microbiology, Rutgers, the State University of New Jersey. His research of first-of-its-kind was published in Nature Biotechnology. Dr Khan served as the founding group leader of Chloroplast Transformation and Biopharming, and head of Biotech Interdisciplinary Division at NIBGE, and is currently serving as the director of the Center of Agricultural Biochemistry and Biotechnology (CABB), University of Agriculture, Faisalabad, Pakistan. Dr Khan has supervised more than 100 PhD candidates, MPhil students, and researchers. He has published more than 100 articles in high impact journals, including Nature, and is the author of several book chapters and books.
Dr. Kangussu obtained his Ph.D. in Physiology and Pharmacology from the Federal University of Minas Gerais (2014) and then undertook postdoctoral fellowships at the department of Physiology and Biophysics (2017) and Morphology (2019). Currently, he is a full professor in the department of Morphology, Federal University of Minas Gerais. He has experience in Physiology, Pharmacology and Morphology. More specifically, his research focuses on the following subjects: vasoactive peptides, renin- angiotensin peptides, hypertension, cerebrovascular and neurodegenerative disease.
Dr. Qinlu Lin obtained his Ph.D. degree in 2002 in Food Science from Hunan Agricultural University and then undertook postdoctoral fellowships from the South China University of Technology (2003-2005). He also studied from the Lund University in Sweden as a visiting scholar (1999-2000). Currently, he is a full professor and Dean of the School of Food Science and Engineering of Center South University of Forestry and Technology. He is also the Director of National Engineering Laboratory for Rice and By-product Process. He is experienced in Food Science, Protein Chemistry and Molecular Nutrition. Notably, Dr. Lin has authored more than 300 articles, having over 1000 total citations. In addition, he holds more than 30 patents and has published five academic monographs.
Currently serves as the deputy head, Department of Bioinformatics and Biostatistics, College of Life Science and Biotechnology, Shanghai Jiaotong University, editor-in-Chief, “Interdisciplinary Sciences- Computational Life Sciences”. Prof. Wei’s research is in the general field of bioinformatics with more than 250 journal papers, 9 monographs with 5000 SCI citations and an H factor of 45, made some ground breaking research works in theoretical and molecular simulations of liquids and biological systems.